NO873069D0 - Fremgangsmaate for fremstilling av hydroksimsyrer av 7-oksabicykloheptan-substituerte etere og tioetere. - Google Patents

Fremgangsmaate for fremstilling av hydroksimsyrer av 7-oksabicykloheptan-substituerte etere og tioetere.

Info

Publication number
NO873069D0
NO873069D0 NO873069A NO873069A NO873069D0 NO 873069 D0 NO873069 D0 NO 873069D0 NO 873069 A NO873069 A NO 873069A NO 873069 A NO873069 A NO 873069A NO 873069 D0 NO873069 D0 NO 873069D0
Authority
NO
Norway
Prior art keywords
tioeters
ocsabicycloheptan
hydroxyxic
acids
procedure
Prior art date
Application number
NO873069A
Other languages
English (en)
Other versions
NO873069L (no
NO168359C (no
NO168359B (no
Inventor
Ravi Kannadikovilakom Varma
Eric Michael Gordon
Ligaya Magbanua Simpkins
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of NO873069D0 publication Critical patent/NO873069D0/no
Publication of NO873069L publication Critical patent/NO873069L/no
Publication of NO168359B publication Critical patent/NO168359B/no
Publication of NO168359C publication Critical patent/NO168359C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO873069A 1986-07-23 1987-07-22 Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksimsyrer av 7-oksabicykloheptan-substituerte etere og tioetere NO168359C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/888,671 US4673685A (en) 1986-07-23 1986-07-23 Hydroximic acids of 7-oxabicycloheptane substituted ethers and thioethers useful in the treatment of thrombotic disease

Publications (4)

Publication Number Publication Date
NO873069D0 true NO873069D0 (no) 1987-07-22
NO873069L NO873069L (no) 1988-01-25
NO168359B NO168359B (no) 1991-11-04
NO168359C NO168359C (no) 1992-02-12

Family

ID=25393633

Family Applications (1)

Application Number Title Priority Date Filing Date
NO873069A NO168359C (no) 1986-07-23 1987-07-22 Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksimsyrer av 7-oksabicykloheptan-substituerte etere og tioetere

Country Status (29)

Country Link
US (1) US4673685A (no)
JP (1) JP2557894B2 (no)
KR (1) KR950010596B1 (no)
AT (1) AT397094B (no)
AU (1) AU599384B2 (no)
BE (1) BE1000141A3 (no)
CA (1) CA1292003C (no)
CH (1) CH674010A5 (no)
DD (1) DD263990A5 (no)
DE (1) DE3724152A1 (no)
DK (1) DK383587A (no)
ES (1) ES2006784A6 (no)
FI (1) FI873207A (no)
FR (1) FR2601953B1 (no)
GB (1) GB2192882B (no)
GR (1) GR871147B (no)
HU (1) HU198495B (no)
IE (1) IE60487B1 (no)
IL (1) IL82919A0 (no)
IT (1) IT1222054B (no)
LU (1) LU86949A1 (no)
NL (1) NL8701742A (no)
NO (1) NO168359C (no)
NZ (1) NZ220677A (no)
PH (1) PH23711A (no)
PT (1) PT85381B (no)
SE (1) SE8702936L (no)
YU (1) YU46321B (no)
ZA (1) ZA874255B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8501035D0 (en) * 1985-01-16 1985-02-20 Senior J Prostaglandins
AU593316B2 (en) * 1986-02-14 1990-02-08 E.R. Squibb & Sons, Inc. Hydroxamic acids of 7-oxabicycloheptane substituted ethers
US4673685A (en) * 1986-07-23 1987-06-16 E. R. Squibb & Sons, Inc. Hydroximic acids of 7-oxabicycloheptane substituted ethers and thioethers useful in the treatment of thrombotic disease
US4925873A (en) * 1988-09-01 1990-05-15 E. R. Squibb & Sons, Inc. Method of treating skin injuries using thromboxane A2 receptor antagonists
US5093329A (en) * 1990-03-12 1992-03-03 Allergan, Inc. Intraocular pressure reducing prostaglandin-like 7-oxabicyclo derivatives

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4242273A (en) * 1977-09-27 1980-12-30 American Cyanamid Company 4-(Monoalkylamino)benzoic acid amides and imidates
US4143054A (en) * 1977-11-04 1979-03-06 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane- and 7-oxabicycloheptene compounds
US4187236A (en) * 1977-11-04 1980-02-05 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane compounds
US4254044A (en) * 1977-11-04 1981-03-03 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane- and 7-oxabicycloheptene compounds
US4220594A (en) * 1977-11-04 1980-09-02 E. R. Squibb & Sons, Inc. Hexa- and octahydro-4,7-epoxyisobenzofuran-1-ol and hexa- and octahydro-5,8-epoxy-1H-2-benzopyran-3-ol
WO1980001381A1 (en) * 1979-01-05 1980-07-10 R Jones Substituted bicyclo (2,2,1) heptanes and hept-2-enes
US4440940A (en) * 1979-10-17 1984-04-03 American Cyanamid Company Anti-atherosclerotic agents
US4228180A (en) * 1979-11-01 1980-10-14 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane and 7-oxabicycloheptene prostaglandin analogs
ZA829068B (en) * 1980-07-01 1983-02-23 Nat Res Dev Prostaglandins
US4628061A (en) * 1981-12-23 1986-12-09 National Research Development Corporation Prostaglandins
US4466979A (en) * 1983-01-21 1984-08-21 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted carbamate prostaglandin analogs useful in treating platelet aggregation and bronchoconstriction
CA1256887A (en) * 1983-03-14 1989-07-04 Steven E. Hall 7-oxabicycloheptane substituted prostaglandin analogs
US4474803A (en) * 1983-03-14 1984-10-02 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted thio prostaglandin analogs useful in treating platelet aggregation and bronchoconstriction
US4513103A (en) * 1983-10-21 1985-04-23 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane ethers useful in the treatment of thrombolytic disease
US4526901A (en) * 1984-01-26 1985-07-02 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted oxamide prostaglandin analogs and their use in treating thrombolytic disease
US4536513A (en) * 1984-03-14 1985-08-20 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted prostaglandin interphenylene analogs useful in the treatment of thrombolytic disease
US4661506A (en) * 1984-11-30 1987-04-28 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane substituted ox prostaglandin analogs
US4654367A (en) * 1986-02-14 1987-03-31 E. R. Squibb & Sons, Inc. Hydroxamic acids of 7-oxabicycloheptane substituted ethers useful as anti-allergy and anti-inflammation agents
US4652578A (en) * 1986-02-24 1987-03-24 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane substituted amide prostaglandin analogs
US4673685A (en) * 1986-07-23 1987-06-16 E. R. Squibb & Sons, Inc. Hydroximic acids of 7-oxabicycloheptane substituted ethers and thioethers useful in the treatment of thrombotic disease

Also Published As

Publication number Publication date
HUT47115A (en) 1989-01-30
GR871147B (en) 1987-12-04
GB2192882B (en) 1990-05-09
IT1222054B (it) 1990-08-31
AT397094B (de) 1994-01-25
NO873069L (no) 1988-01-25
GB8714621D0 (en) 1987-07-29
FR2601953B1 (fr) 1990-11-16
NL8701742A (nl) 1988-02-16
YU46321B (sh) 1993-05-28
HU198495B (en) 1989-10-30
IE871675L (en) 1988-01-23
ES2006784A6 (es) 1989-05-16
NO168359C (no) 1992-02-12
GB2192882A (en) 1988-01-27
DD263990A5 (de) 1989-01-18
NZ220677A (en) 1989-12-21
NO168359B (no) 1991-11-04
LU86949A1 (fr) 1988-02-02
CH674010A5 (no) 1990-04-30
IL82919A0 (en) 1987-12-20
KR880001660A (ko) 1988-04-25
US4673685A (en) 1987-06-16
AU599384B2 (en) 1990-07-19
ZA874255B (en) 1988-02-24
AU7444887A (en) 1988-01-28
SE8702936D0 (sv) 1987-07-22
ATA174887A (de) 1993-06-15
DK383587D0 (da) 1987-07-22
SE8702936L (sv) 1988-04-07
CA1292003C (en) 1991-11-12
JPS6335576A (ja) 1988-02-16
IE60487B1 (en) 1994-07-27
PT85381B (pt) 1990-04-30
IT8721328A0 (it) 1987-07-16
JP2557894B2 (ja) 1996-11-27
KR950010596B1 (ko) 1995-09-20
PH23711A (en) 1989-09-27
FI873207A0 (fi) 1987-07-21
DE3724152A1 (de) 1988-02-04
YU138187A (en) 1988-12-31
BE1000141A3 (fr) 1988-05-03
FR2601953A1 (fr) 1988-01-29
PT85381A (en) 1987-08-01
FI873207A (fi) 1988-01-24
DK383587A (da) 1988-01-24

Similar Documents

Publication Publication Date Title
NO874530L (no) Fremgangsmaate for fremstilling av nor-statin- eller nor-cyklostatin-polypeptider.
NO870579L (no) Fremgangsmaate for fremstilling av indolizin-derivater.
NO872712D0 (no) Fremgangsmaate for fremstilling av kalsiumholdige preparater.
NO880262D0 (no) Fremgangsmaate for fremstilling av b avermectiner.
NO874467D0 (no) Fremgangsmaate for fremstilling av 3-pyrrolidinoler.
NO882940D0 (no) Fremgangsmaate for fremstilling av castanosperminestere og glycosider.
NO885002D0 (no) FremgangsmŸte for fremstilling av sialocylglycerolipider.
NO882730D0 (no) Fremgangsmaate for fremstilling av aminocyklopentyletere.
NO873197D0 (no) Bedoevelsespreparat og fremgangsmaate for anvendelse av dette.
NO881713D0 (no) Fremgangsmaate for fremstilling av di-t-butylfenyl-alkyl og benzylethere.
NO873069D0 (no) Fremgangsmaate for fremstilling av hydroksimsyrer av 7-oksabicykloheptan-substituerte etere og tioetere.
NO873400D0 (no) Fremgangsmaate for fremstilling av sulfidfri alkalivaeske.
NO874759D0 (no) Fremgangsmaate til fremstilling av purin-9-ylalkylenoksymetylfosfonsyrer.
NO863113D0 (no) Fremgangsmaate for fremstilling av heterocyclocarbonyl- og acetyl-thiazoloner.
NO166726C (no) Fremgangsmaate for fremstilling av arylglycidyletere og 3-substituerte 1-alkylamino-2-propanoler.
NO168941C (no) Fremgangsmaate for fremstilling av mercaptoacylprolin.
NO905543D0 (no) Fremgangsmaate for fremstilling og anvendelse av aminopyridinylmetanoler og aminometylpyridinaminer.
NO874199D0 (no) Fremgangsmaate for fremstilling av imidazo-pyridinonderivater.
NO885446D0 (no) Fremgangsmaate for fremstilling av kinolincarboxylsyrer.
NO872199D0 (no) Analogifremgangsmaate for fremstilling av alkoxyalkyl- og alkylmercaptoalkylsubstituerte benzofuroisokinoliner.
NO880345L (no) Fremgangsmaate for fremstilling av alkyl-tert-butyletere.
NO880834D0 (no) Fremgangsmaate for fremstilling av heterocyclyl-2-propyn-1-aminer.
NO880106D0 (no) Fremgangsmaate til fremstilling av kalknitrogen.
NO874698L (no) Fremgangsmaate for fremstilling av 2-guanidinothiazolderivater.
NO875253D0 (no) Fremgangsmaate for fremstilling av methyl-4-oxo-5-tetradecynoat.